Patent · US Active

Hepatitis C virus inhibitors

US9527885B2 · kind B2 · utility

0Cited by

14References

8Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Sheldon Hiebert · Steinbach, CA
Ramkumar Rajamani · Wallingford, US
Li-Qiang Sun · Foster City, US
Eric Mull · Guilford, US
Eric P. Gillis · Cheshire, US
Michael S. Bowsher · Prospect, US
Qian Zhao · Louisville, US
Nicholas A. Meanwell · East Hampton, US
Kishore V. Renduchintala · Hyderabad, IN
Kandhasamy Sarkunam · Hosur, IN
Pulicharla Nagalakshmi · Bengaluru, IN
P.V.K. Suresh Babu · Bengaluru, IN
Paul Michael Scola · Glastonbury, US

Key dates

Filing date	Jan 8, 2015
Grant date	Dec 27, 2016
Priority date	—
Expiry date	Jan 8, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Hepatitis C virus inhibitors having the general formula (I)are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.